Double-Blind Active-Control Trials : Beware the Comparator You KeepDINUBILE, Mark J.Clinical infectious diseases. 2008, Vol 47, Num 8, pp 1064-1067, issn 1058-4838, 4 p.Article

Skepticism : A lost clinical artDINUBILE, Mark J.Clinical infectious diseases. 2000, Vol 31, Num 2, pp 513-518, issn 1058-4838Article

Sustained Decline in Cases of Rotavirus Gastroenteritis Presenting to the Children's Hospital of Philadelphia in the New Rotavirus Vaccine EraCLARK, H. Fred; LAWLEY, Diane; MATTHIJNSSENS, Jelle et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 8, pp 699-702, issn 0891-3668, 4 p.Article

Invasive candidiasis in cancer atients : observations from a randomized clinical trialDINUBILE, Mark J; HILLE, Darcy; SABLE, Carole A et al.The Journal of infection. 2005, Vol 50, Num 5, pp 443-449, issn 0163-4453, 7 p.Article

Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofunginDINUBILE, Mark J; LUPINACCI, Robert J; BERMAN, Rayanne S et al.AIDS research and human retroviruses. 2002, Vol 18, Num 13, pp 903-908, issn 0889-2229, 6 p.Article

Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionSTEIGBIGEL, Roy T; COOPER, David A; KATLAMA, Christine et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 339-354, issn 0028-4793, 16 p.Article

Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: An analysis of four different protease inhibitorsCOPLAN, Paul M; NIKAS, Alexander; JAPOUR, Anthony et al.AIDS research and human retroviruses. 2003, Vol 19, Num 6, pp 449-455, issn 0889-2229, 7 p.Article

Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapySAAH, Alfred J; HAAS, David W; CONDRA, Jon H et al.The Journal of infectious diseases. 2003, Vol 187, Num 7, pp 1157-1162, issn 0022-1899, 6 p.Article

Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infectionHIRSCH, Martin S; STEIGBIGEL, Roy T; LEAVITT, Randi Y et al.Clinical infectious diseases. 2003, Vol 37, Num 8, pp 1119-1124, issn 1058-4838, 6 p.Article

Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery: A Randomized TrialFOWLER, Vance G; ALLEN, Keith B; CHAN, Ivan S. F et al.JAMA, the journal of the American Medical Association. 2013, Vol 309, Num 13, pp 1368-1378, issn 0098-7484, 11 p.Article

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy AdultsPRIDDY, Frances H; BROWN, Deborah; BROWN, Stephen J et al.Clinical infectious diseases. 2008, Vol 46, Num 11, pp 1769-1781, issn 1058-4838, 13 p.Article

Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections : observations from 2 randomized comparative clinical trials of ertapenem therapyDINUBILE, Mark J; FRIEDLAND, Ian R; CHAN, Christina Y et al.Diagnostic microbiology and infectious disease. 2007, Vol 58, Num 4, pp 491-494, issn 0732-8893, 4 p.Article

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adultsYOUNG, Benjamin; FISCHL, Margaret A; WILSON, Helene M et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 5, pp 478-482, issn 1525-4135, 5 p.Article

Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantationDINUBILE, Mark J; STOSSEL, Thomas P; LJUNGHUSEN, Olof C et al.Blood. 2002, Vol 100, Num 13, pp 4367-4371, issn 0006-4971, 5 p.Article

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitisVILLANUEVA, Alvaro; ARATHOON, Eduardo G; GOTUZZO, Eduardo et al.Clinical infectious diseases. 2001, Vol 33, Num 9, pp 1529-1535, issn 1058-4838Article

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patientsPAPASAVVAS, Emmanouil; PISTILLI, Maxwell; MOUNZER, Karam C et al.AIDS (London). 2009, Vol 23, Num 3, pp 369-375, issn 0269-9370, 7 p.Article

EFFICACY OF PENTAVALENT HUMAN-BOVINE (WC3) REASSORTANT ROTAVIRUS VACCINE BASED ON BREASTFEEDING FREQUENCYGOVEIA, Michelle G; DINUBILE, Mark J; DALLAS, Michael J et al.The Pediatric infectious disease journal. 2008, Vol 27, Num 7, pp 656-658, issn 0891-3668, 3 p.Article

HIV Seroconversion without Infection after Receipt of Adenovirus-Vectored HIV Type 1 VaccineQUIRK, Erin K; MOGG, Robin; BROWN, Deborah D et al.Clinical infectious diseases. 2008, Vol 47, Num 12, pp 1593-1599, issn 1058-4838, 7 p.Article

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide : 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)ROSSI, Flavia; BAQUERO, Fernando; HSUEH, Po-Ren et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 1, pp 205-210, issn 0305-7453, 6 p.Article

Complicated infections of skin and skin structures: when the infection is more than skin deepDINUBILE, Mark J; LIPSKY, Benjamin A.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, pp ii37-ii50, issn 0305-7453, SUP2Article

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasisVILLANUEVA, Alvaro; GOTUZZO, Eduardo; ARATHOON, Eduardo G et al.The American journal of medicine. 2002, Vol 113, Num 4, pp 294-299, issn 0002-9343Article

Refinement of Stopping Rules During Treatment of Hepatitis C Genotype 1 Infection With Boceprevir and Peginterferon/RibavirinJACOBSON, Ira M; MARCELLIN, Patrick; WEIPING DENG et al.Hepatology (Baltimore, Md.). 2012, Vol 56, Num 2, pp 567-575, issn 0270-9139, 9 p.Article

Boceprevir for Untreated Chronic HCV Genotype 1 InfectionPOORDAD, Fred; MCCONE, Jonathan; DINUBILE, Mark J et al.The New England journal of medicine. 2011, Vol 364, Num 13, pp 1195-1206, issn 0028-4793, 12 p.Article

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRKROCKSTROH, Jiirgen K; LENNOX, Jeffrey L; DINUBILE, Mark J et al.Clinical infectious diseases. 2011, Vol 53, Num 8, pp 807-816, issn 1058-4838, 10 p.Article

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialERON, Joseph; ROCKSTROH, Jürgen K; NELSON, Mark et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 12, pp 907-915, issn 1473-3099, 9 p.Article